Improved inference of population histories by integrating genomic and epigenomic data

  1. Department of Environment and Biodiversity, Paris Lodron University of Salzburg
  2. Professorship for Population Genetics, Department of Life Science Systems, Technical University of Munich
  3. Professorship for Plant Epigenomics, Department of Molecular Life Sciences, Technical University of Munich

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Jeffrey Ross-Ibarra
    University of California, Davis, Davis, United States of America
  • Senior Editor
    Detlef Weigel
    Max Planck Institute for Biology Tübingen, Tübingen, Germany

Reviewer #1 (Public Review):

The authors developed an extension to the pairwise sequentially Markov coalecent model that allows to simultaneously analyze multiple types of polymorphism data. In this paper, they focus on SNPs and DNA methylation data. Since methylation markers mutate at a much faster rate than SNPs, this potentially gives the method better power to infer size history in the recent past. Additionally, they explored a model where there are both local and regional epimutational processes.

Integrating additional types of heritable markers into SMC is a nice idea which I like in principle. However, a major caveat to this approach seems to be a strong dependence on knowing the epimutation rate. In Fig. 6 it is seen that, when the epimutation rate is known, inferences do indeed look better; but this is not necessarily true when the rate is not known. A roughly similar pattern emerges in Supp. Figs. 4-7; in general, results when the rates have to be estimated don't seem that much better than when focusing on SNPs alone. This carries over to the real data analysis too: the interpretation in Fig. 7 appears to hinge on whether the rates are known or estimated, and the estimated rates differ by a large amount from earlier published ones.

Overall, this is an interesting research direction, and I think the method may hold more promise as we get more and better epigenetic data, and in particular better knowledge of the epigenetic mutational process. At the same time, I would be careful about placing too much emphasis on new findings that emerge solely by switching to SNP+SMP analysis.

Reviewer #2 (Public Review):

A limitation in using SNPs to understand recent histories of genomes is their low mutation frequency. Tellier et al. explore the possibility of adding hypermutable markers to SNP based methods for better resolution over short time frames. In particular, they hypothesize that epimutations (CG methylation and demethylation) could provide a useful marker for this purpose. Individual CGs in Arabidopsis tends to be either close to 100% methylated or close to 0%, and are inherited stably enough across generations that they can be treated as genetic markers. Small regions containing multiple CGs can also be treated as genetic markers based on their cumulative methylation level. In this manuscript, Tellier et al develop computational methods to use CG methylation as a hypermutable genetic marker and test them on theoretical and real data sets. They do this both for individual CGs and small regions. My review is limited to the simple question of whether using CG methylation for this purpose makes sense at a conceptual level, not at the level of evaluating specific details of the methods. I have a small concern in that it is not clear that CG methylation measurements are nearly as binary in other plants and other eukaryotes as they are in Arabidopsis. However, I see no reason why the concept of this work is not conceptually sound. Especially in the future as new sequencing technologies provide both base calling and methylating calling capabilities, using CG methylation in addition to SNPs could become a useful and feasible tool for population genetics in situations where SNPs are insufficient.

Reviewer #3 (Public Review):

I very much like this approach and the idea of incorporating hypervariable markers. The method is intriguing, and the ability to e.g. estimate recombination rates, the size of DMRs, etc. is a really nice plus. I am not able to comment on the details of the statistical inference, but from what I can evaluate it seems sound and reasonable. This is an exciting new avenue for thinking about inference from genomic data. I have a few concerns about the presentation and then also questions about the use of empirical methylation data sets.

I think a more detailed description of demographic accuracy is warranted. For example, in L245 MSMC2 identifies the bottleneck (albeit smoothed) and only slightly overestimates recent size. In the same analysis the authors' approach with unknown mu infers a nonexistent population increase by an order of magnitude that is not mentioned.

Similarly, it seems problematic that (L556) the approach requiring estimation of site and region parameters (as would presumably be needed in most empirical systems like endangered nonmodel species mentioned in the introduction) does no better than using only SNPs. Overall, I think a more objective and perhaps quantitative comparison of approaches is warranted.

The authors simulate methylated markers at 2% (and in some places up to 20%). In many plant genomes a large proportion of cytosines are methylated (e.g. 70% in maize: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496265/). I don't know what % of these may be polymorphic, but this leads to an order of magnitude more methylated cytosines than there are SNPs. Couldn't this mean that any appreciable error in estimating methylation threatens to be of a similar order of magnitude to the SNP data? I would welcome the authors' thoughts here.

A few points of discussion about the biology of methylation might be worth including. For example, methylation can differ among cell types or cells within a tissue, yet sequencing approaches evaluate a pool of cells. This results in a reasonable fraction of sites having methylation rates not clearly 0 or 1. How does this variation affect the method? Similarly, while the authors cite literature about the stable inheritance of methylation, a sentence or so more about the time scale over which this occurs would be helpful. Finally, in some species methylated cytosines have mutation rates an order of magnitude higher than other nucleotides. The authors mention they assume independence, but how would violation of this assumption affect their inference?

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation